India · Delayed Price · Currency is INR HDFC Life Insurance Company Earnings Call Transcripts
Fiscal Year 2026
-
Maintained top-three market position with 7% APE growth and strong retail protection gains, despite margin pressure from GST and regulatory changes. Embedded value rose to INR 62,139 crore, with a 15% operating return, and capital raise plans will further strengthen solvency.
-
Individual WRP and protection segments outpaced industry growth, with strong margin resilience despite regulatory headwinds. Persistency challenges were cohort-specific and are being addressed, while margin impact from GST is being rapidly neutralized.
-
H1-FY26 delivered 10% APE growth, 9% PAT rise, and stable margins despite GST-related headwinds. Protection and annuity segments outperformed, with strong Tier 2/3 market expansion and robust agency/broker channel growth. Margin normalization is expected by FY27.
-
Q1 FY2026 saw robust growth in APE, VNB, and profits, with market share gains and steady margins. Product mix remains balanced, and outlook is positive for H2, with continued investments in distribution and technology.
Fiscal Year 2025
-
Individual APE grew 18% in FY 2025, with VNB up 13% and profit after tax rising 15%. Market share expanded, persistency improved, and all channels saw double-digit growth. Investments in technology and distribution are expected to keep margins range-bound while supporting long-term growth.
-
Nine-month FY25 saw 22% individual WRP growth, 14% VNB growth, and a 25.1% new business margin, with persistency and solvency ratios improving. Surrender regulation impact was contained, and distribution diversification continues.
-
Delivered strong H1 FY25 growth with 28% increase in individual premiums, 17.4% VNB growth, and improved market share. Margins compressed to 24.6% due to product mix and repricing lag, but full-year growth and VNB guidance remain robust.
-
Q1 FY25 saw 31% year-over-year growth in individual APE, strong gains in protection and non-par segments, and a 15% rise in profit after tax. Margins compressed to 25% due to product mix and investments, with regulatory changes expected to impact margins by 100 bps, though the company remains confident in its growth trajectory.